How HPV disables the cell's two main tumour suppressors
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Cancer is usually described as a cell gaining something: a mutation, a growth signal. HPV works the other way round.
It does not add a new ability. It removes the two safeguards that would otherwise stop a damaged cell in its tracks, and then removes the limit on how many times that cell can divide.
Related pages: Anal cancer
The bottom line
- E7 disables the retinoblastoma protein, pRb, which normally holds the cell-division switch off.
- E6 marks p53 for destruction, removing the cell's damage check and self-destruct option.
- E6 also reactivates telomerase, removing the usual limit on cell divisions.
- The result is a cell that divides constantly, cannot repair or kill itself, and does not age out.
- Why cells carrying these changes still take years to become cancer.
- Whether the E6 and E7 proteins can be targeted directly as a treatment.
The story, step by step
What the evidence labels mean
What the cell normally has
What happens
Human cells have layered defences against becoming cancer, and two of them matter here.
What the research shows
- pRb, the retinoblastoma protein, holds the cell at a checkpoint and releases it to divide only when conditions are right.
- p53 monitors DNA damage. If damage is found it halts division for repair, and if the damage cannot be repaired it triggers apoptosis, the cell's self-destruct program.
- p53 is sometimes called the guardian of the genome, and it is the most commonly mutated gene across human cancers.
- Most cancers disable these two by mutating them. HPV disables them without mutating anything.
Why it matters
A virus achieving by protein what other cancers achieve by mutation is the reason HPV-driven tumours have relatively few mutations of their own.
What's still uncertain
- Both proteins have many other functions, and not all consequences of losing them are understood.
Read more
Next: E7 and pRb
The division switch jammed on
What happens
E7 is a small protein with one consequential job.
What the research shows
- It binds pRb and targets it for destruction by the cell's own protein disposal system.
- Without pRb, the checkpoint is gone and the transcription factors that drive division are permanently released.
- The cell divides when it should not, including cells in the upper layers that should have stopped dividing and matured.
- The cell detects the loss and responds by producing large amounts of a protein called p16, which is why p16 staining is used in the laboratory as a marker of HPV-driven disease.
- That compensatory response fails, because the brake it is trying to apply has already been destroyed.
Why it matters
p16 overexpression is how a pathologist can tell an HPV-driven cancer from one that is not, and it is a direct fingerprint of what E7 has done.
What's still uncertain
- p16 staining is a surrogate marker and can occasionally be positive without HPV.
Read more
- Palefsky et al., New England Journal of Medicine 2022: Treatment of anal high-grade squamous intraepithelial lesions (ANCHOR trial)Journal
- OwieClear: How HPV takes over anal cellsOwieClear
Next: E6 and p53
The guardian removed
What happens
Constant unwanted division would normally be caught by p53, which would stop the cell or kill it. E6 prevents that.
What the research shows
- E6 recruits a host enzyme, E6AP, and together they tag p53 for rapid destruction.
- With p53 gone, DNA damage is not detected, division is not halted for repair, and apoptosis is not triggered.
- Errors accumulate from one division to the next, and the genome becomes progressively unstable.
- This is why E6 and E7 are described as working together: E7 forces division, and E6 removes the response that would stop it.
Why it matters
Either protein alone would be contained. Together they remove both the accelerator's limiter and the brake.
What's still uncertain
- E6 has additional targets beyond p53, and their contribution is still being characterized.
Read more
Next: Telomerase
The ageing clock switched off
What happens
There is a third mechanism, and it is what makes the damaged cells permanent.
What the research shows
- Chromosomes end in repeated sequences called telomeres, which shorten slightly with every division.
- When telomeres become too short, the cell stops dividing and enters senescence. This is a built-in limit on how many times a cell can divide.
- Telomerase rebuilds telomeres. It is active in stem cells and switched off in most mature cells.
- E6 reactivates telomerase, so the abnormal cells never run out of divisions.
- Combined with the loss of p53 and pRb, this produces a cell line that divides indefinitely and accumulates damage indefinitely.
Why it matters
Immortality is the third ingredient. Without it the abnormal clone would eventually stall on its own.
What's still uncertain
- Telomerase activation is common across cancers and is not unique to HPV-driven ones.
Read more
Next: Why it still takes years
A process, not a switch
What happens
All of the above can be present and the person still does not have cancer.
What the research shows
- Disabling the tumour suppressors creates a cell prone to accumulating damage. It does not by itself create an invasive cancer.
- Additional genetic changes accumulate over years before cells breach the basement membrane and invade.
- That long interval is why precancer exists as a findable, treatable stage.
- It is also why screening works in the groups where it is offered: there is a window of years in which to intervene.
- The vaccine works further upstream still, preventing the infection that starts the whole sequence.
Why it matters
The slowness of this process is the single most useful fact about it, because everything preventive depends on that time.
What's still uncertain
- Why some high-grade lesions progress and others regress is not predictable in an individual.